FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2141937666> ?p ?o ?g. }

• W2141937666 endingPage "7120" @default.
• W2141937666 startingPage "7112" @default.
• W2141937666 abstract "To determine the maximum tolerated dose of administrating CI-1033, an oral 4-anilinoquinazoline that irreversibly inhibits the tyrosine kinase domain of all erbB subfamilies, on an intermittent schedule, and assess the interaction of CI-1033 with food on the pharmacokinetic behavior.Escalating doses of CI-1033 from a dose level of 300 mg/day for 7 days every other week were administered to patients with advanced solid malignancies. Plasma concentration-time data sets from all evaluable patients were used to develop a population pharmacokinetic model. Noncompartmental methods were used to independently assess the effect of a high-fat meal on CI-1033 absorption and bioavailability.Twenty-four patients were treated with 69 twenty-eight day courses. The incidence of unacceptable toxicity, principally diarrhea and skin rash, was observed at the 300 mg/day dose level. At the 250 mg/day level, toxicity was manageable, and protracted administration was feasible. A one-compartment linear model with first-order absorption and elimination adequately described the pharmacokinetic disposition. CL/F, apparent volume of distribution (Vd/F), and ka (mean +/- relative SD) were 280 L/hour +/- 33%, 684 L +/- 20%, and 0.35 hour(-1)+/- 69%, respectively. Cmax values were achieved in 2 to 4 hours. Systemic CI-1033 exposure was largely unaffected by administration of a high-fat meal. At 250 mg, concentration values exceeded IC50 values required for prolonged pan-erbB tyrosine kinase inhibition in preclinical assays.The recommended dose on this schedule is 250 mg/day. Its tolerability and the biological relevance of concentrations achieved at the maximal tolerated dose warrant consideration of disease-directed evaluations. This intermittent treatment schedule can be used without regard to meals." @default.
• W2141937666 created "2016-06-24" @default.
• W2141937666 creator A5001166747 @default.
• W2141937666 creator A5002037553 @default.
• W2141937666 creator A5011905014 @default.
• W2141937666 creator A5023878438 @default.
• W2141937666 creator A5039144013 @default.
• W2141937666 creator A5060992997 @default.
• W2141937666 creator A5064953304 @default.
• W2141937666 creator A5070570779 @default.
• W2141937666 creator A5072139073 @default.
• W2141937666 creator A5072378199 @default.
• W2141937666 creator A5089962252 @default.
• W2141937666 date "2004-11-01" @default.
• W2141937666 modified "2023-10-14" @default.
• W2141937666 title "Administration of CI-1033, an Irreversible Pan-erbB Tyrosine Kinase Inhibitor, Is Feasible on a 7-Day On, 7-Day Off Schedule" @default.
• W2141937666 cites W1550111394 @default.
• W2141937666 cites W1991385244 @default.
• W2141937666 cites W1995993550 @default.
• W2141937666 cites W1999243658 @default.
• W2141937666 cites W2003131098 @default.
• W2141937666 cites W2003418168 @default.
• W2141937666 cites W2014053430 @default.
• W2141937666 cites W2016008185 @default.
• W2141937666 cites W2016729671 @default.
• W2141937666 cites W2025464344 @default.
• W2141937666 cites W2026175788 @default.
• W2141937666 cites W2043696829 @default.
• W2141937666 cites W2059456865 @default.
• W2141937666 cites W2079244398 @default.
• W2141937666 cites W2079275926 @default.
• W2141937666 cites W2081625464 @default.
• W2141937666 cites W2087082455 @default.
• W2141937666 cites W2104995567 @default.
• W2141937666 cites W2116398087 @default.
• W2141937666 cites W2116991201 @default.
• W2141937666 cites W2121831273 @default.
• W2141937666 cites W2123206362 @default.
• W2141937666 cites W2127627123 @default.
• W2141937666 cites W2136028687 @default.
• W2141937666 cites W2139937771 @default.
• W2141937666 cites W2152037201 @default.
• W2141937666 cites W2163252214 @default.
• W2141937666 doi "https://doi.org/10.1158/1078-0432.ccr-04-1187" @default.
• W2141937666 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15534081" @default.
• W2141937666 hasPublicationYear "2004" @default.
• W2141937666 type Work @default.
• W2141937666 sameAs 2141937666 @default.
• W2141937666 citedByCount "72" @default.
• W2141937666 countsByYear W21419376662012 @default.
• W2141937666 countsByYear W21419376662013 @default.
• W2141937666 countsByYear W21419376662014 @default.
• W2141937666 countsByYear W21419376662015 @default.
• W2141937666 countsByYear W21419376662016 @default.
• W2141937666 countsByYear W21419376662018 @default.
• W2141937666 countsByYear W21419376662019 @default.
• W2141937666 countsByYear W21419376662020 @default.
• W2141937666 countsByYear W21419376662023 @default.
• W2141937666 crossrefType "journal-article" @default.
• W2141937666 hasAuthorship W2141937666A5001166747 @default.
• W2141937666 hasAuthorship W2141937666A5002037553 @default.
• W2141937666 hasAuthorship W2141937666A5011905014 @default.
• W2141937666 hasAuthorship W2141937666A5023878438 @default.
• W2141937666 hasAuthorship W2141937666A5039144013 @default.
• W2141937666 hasAuthorship W2141937666A5060992997 @default.
• W2141937666 hasAuthorship W2141937666A5064953304 @default.
• W2141937666 hasAuthorship W2141937666A5070570779 @default.
• W2141937666 hasAuthorship W2141937666A5072139073 @default.
• W2141937666 hasAuthorship W2141937666A5072378199 @default.
• W2141937666 hasAuthorship W2141937666A5089962252 @default.
• W2141937666 hasConcept C112705442 @default.
• W2141937666 hasConcept C126322002 @default.
• W2141937666 hasConcept C139254425 @default.
• W2141937666 hasConcept C181389837 @default.
• W2141937666 hasConcept C197934379 @default.
• W2141937666 hasConcept C22979827 @default.
• W2141937666 hasConcept C2778375690 @default.
• W2141937666 hasConcept C2908647359 @default.
• W2141937666 hasConcept C29730261 @default.
• W2141937666 hasConcept C71924100 @default.
• W2141937666 hasConcept C98274493 @default.
• W2141937666 hasConcept C99454951 @default.
• W2141937666 hasConceptScore W2141937666C112705442 @default.
• W2141937666 hasConceptScore W2141937666C126322002 @default.
• W2141937666 hasConceptScore W2141937666C139254425 @default.
• W2141937666 hasConceptScore W2141937666C181389837 @default.
• W2141937666 hasConceptScore W2141937666C197934379 @default.
• W2141937666 hasConceptScore W2141937666C22979827 @default.
• W2141937666 hasConceptScore W2141937666C2778375690 @default.
• W2141937666 hasConceptScore W2141937666C2908647359 @default.
• W2141937666 hasConceptScore W2141937666C29730261 @default.
• W2141937666 hasConceptScore W2141937666C71924100 @default.
• W2141937666 hasConceptScore W2141937666C98274493 @default.
• W2141937666 hasConceptScore W2141937666C99454951 @default.
• W2141937666 hasIssue "21" @default.
• W2141937666 hasLocation W21419376661 @default.
• W2141937666 hasLocation W21419376662 @default.
• W2141937666 hasOpenAccess W2141937666 @default.

• next